ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Phase2a RossRiver Virus Clinical Trial Recruitment Finalised
Published: 28/08/18, 12:04pm (AEST)•2 pages